Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Falconer

Showing results (151-160 of 155) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 155 results.
British Journal of Cancer|July 29, 2004
ATM polymorphisms as risk factors for prostate cancer developmentS Angèle, A Falconer, S M Edwards, et al.
Nanotheranostics|November 15, 2019
Theranostic nanoparticles enhance the response of glioblastomas to radiationWei Wu, Jessica L Klockow, Suchismita Mohanty, et al.
Journal of Medical Genetics|February 4, 2005
The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathyJ Bond, K Flintoff, J Higgins, et al.
British Journal of Cancer|August 26, 2010
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosisS M Edwards, D G R Evans, Q Hope, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Pageof 16

Showing results (151-160 of 155) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 155 results.
British Journal of Cancer|July 29, 2004
ATM polymorphisms as risk factors for prostate cancer developmentS Angèle, A Falconer, S M Edwards, et al.
Nanotheranostics|November 15, 2019
Theranostic nanoparticles enhance the response of glioblastomas to radiationWei Wu, Jessica L Klockow, Suchismita Mohanty, et al.
Journal of Medical Genetics|February 4, 2005
The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathyJ Bond, K Flintoff, J Higgins, et al.
British Journal of Cancer|August 26, 2010
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosisS M Edwards, D G R Evans, Q Hope, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Pageof 16